Incorporated in 2008, Yatharth Hospital and Trauma Care Services Limited is a multi-care hospital chain. They rank among the top 10 largest private hospitals in the National Capital Region of Delhi.

Yatharth Hospital presently operates three super specialty hospitals situated in Delhi NCR, i.e., at Noida, Greater Noida, and Noida Extension, Uttar Pradesh. Further, Noida Extension Hospital has 450 beds and is one of the largest hospitals around the area.

To extend its operations and services, the company acquired a 305-bedded multi-specialty hospital in Orchha, Madhya Pradesh. This too is among the largest hospital in the locality.

A team of 370 doctors is engaged with the company. They offer healthcare services across numerous specialties and super specialties.

The super specialty or Centres of Excellence (COE) of the hospital includes:

Centre of Medicine, Centre of General Surgery, Centre of Gastroenterology, Centre of Cardiology, Centre of Nephrology & Urology, Centre of Pulmonology, Centre of Neurosciences, Centre of Paediatrics, Centre of Gynaecology, Centre of Orthopaedics and Spine & Rheumatology.

For year/ period ended ( in Cr.)

• Among the leading super-specialty hospital in Delhi NCR with diverse specialty and payer mix;
• Advanced and high-end medical equipment and technology;
• Ability to attract quality doctors, nurses, paramedical, and other staff;
• Experienced and qualified professional management team with strong execution track record; and
• Track record of stable operating and financial performance and growth.

1. Repayment/ prepayment, in full or part, of certain borrowings availed by the Company.
2. Repayment/ prepayment, in full or part, of certain borrowings availed by the Subsidiaries, namely, AKS Medical & Research Centre Private Limited and Ramraja Multispeciality Hospital & Trauma Centre Private Limited.
3. Funding capital expenditure expenses of the Company for two hospitals, namely, Noida Hospital and Greater Noida Hospital.
4. Funding capital expenditure expenses of the Subsidiaries, AKS and Ramraja, for respective hospitals operated by them.
5. Funding inorganic growth initiatives through acquisitions and other strategic initiatives.
6. General corporate purposes.

• At the upper band of offer price, the IPO is valued at 30x. Hence, investors may subscribe it with a long-term perspective.